CHRONIC MEYLOID LEUKEMIA MOLECULAR CYTARABINE TYROSINE KINASE INHIBITORS DISCONTINUATION EUTOS SCORE TRANSPORTER GENES KIT K5091 PHARMAECONOMIC STUDY F359V FIRST-LINE MR4.5 VIRAL HEPATITIS REACTIVATION CML BCR/ABL GENE STEM CELL TRANSPLANTATION MESILATO BCR-ABL CHRONIC MYELOID LEUKAEMIA LEUCEMIA MIELÓIDE CRÔNICA (LMC-PB) MOLECULAR RESPONSE LEUCEMIA MIELOIDE CRÔNICA BRAZIL CML-CP NON-MYELOABLATIVE BCR-ABL MUTATIONS CHILDREN AND ADOLESCENTS ANEMIA FALCIFORME POLYMORPHISMS DASATINIB LOW EDUCATION LEVEL NILOTINIB K562 CELLS LEUCEMIA MIELÓIDE CRÔNICA (LMC) IRS-1 CHRONIC MYELOID LEUCEMIA PHASE 2 MYELOGENOUS LEUKEMIA MITOXANTRONE OCULAR CHRONIC MYELOGENOUS LEUKEMIA CHRONIC MYELOID LEUCEMIA (CML) LASOR BCL/ABL START TREATMENT-FREE REMISSION PROTEIN-CODING CYTOGENETIC CYTOGENETIC REMISSION FRONTLINE LEUCEMIA MIELÓDE CRÔNICA DASATINIB-TREATED LALNET LEUCEMIA MIELÓIDE CRÔNICA CITARABINA OBSERVATIONAL CRONIC LYMPHOCYTIC LEUKEMIA RNAS BCR/ABL GENERIC CHRONIC PHASE CHRONIC MYELOID LEUKEMIA